Afuco™ Anti-CD4 ADCC Recombinant Antibody (Keliximab), ADCC Enhanced (CAT#: AFC-TAB-171)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD4. Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Immunogen
  • Recombinant fragment (Human) corresponding to the external domain.
  • Host Species
  • Chimeric
  • Derivation
  • Chimeric (primate/human)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Clone
  • Keliximab
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP
  • Conjugate
  • Unconjugated
  • Generic Name
  • Keliximab
  • Related Disease
  • Rheumatoid arthritis (RA)

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Keliximab; 174722-30-6; IDEC CE9.1; SB210396; CD4; CD4 molecule; CD4 antigen (p55), T cell surface glycoprotein CD4; T-cell surface glycoprotein CD4; CD4 receptor; CD4 antigen (p55); T-cell surface antigen T4/Leu-3; CD4mut;

Related Resources

  • Biosimilar Overview
  • Related Diseases
Please refer to Keliximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Keliximab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Keliximab"

Anti-Human CD4 Recombinant Antibody (Keliximab)
Recombinant monoclonal antibody to CD4. Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.

See other products for "CD4"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Immunotoxin Fab Fragment Antibody Mouse Antibody Humanized Antibody Chimeric Antibody Fab Glycosylation Blocking Antibody Neutralizing Antibody Rabbit Monoclonal Antibody Recombinant Antibody scFv Fragment Antibody ADCC Enhanced Antibody Antibody Magnetic Beads
CAT Product Name Application Type
TAB-039 Anti-Human CD4 Recombinant Antibody (Zanolimumab) Neut, ELISA, IF, IP, FuncS, FC, IHC IgG1 - kappa

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-171. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare